Cannapharmarx Inc (CPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,132 | -9,906 | 3,689 | -8,531 | -8,833 |
| Depreciation Amortization | N/A | N/A | 128 | 774 | 1,258 |
| Accounts receivable | -1,011 | -2 | N/A | N/A | N/A |
| Other Working Capital | 432 | 24 | -821 | 3,948 | -421 |
| Other Operating Activity | 10,922 | 8,186 | -5,270 | 2,361 | 5,581 |
| Operating Cash Flow | $-789 | $-1,697 | $-2,275 | $-1,448 | $-2,415 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | -81 | -116 | -6 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -40 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 539 |
| Investing Cash Flow | $-6 | $0 | $-81 | $-116 | $494 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 150 | 406 | 913 | 584 |
| Debt Issued | 794 | 1,549 | N/A | 55 | 239 |
| Debt Repayment | N/A | N/A | 1,947 | N/A | -255 |
| Common Stock Issued | N/A | N/A | N/A | 437 | 291 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 481 |
| Financing Cash Flow | $794 | $1,699 | $2,353 | $1,405 | $1,341 |
| Exchange Rate Effect | N/A | N/A | N/A | 134 | 273 |
| Beginning Cash Position | 2 | 1 | 2 | 28 | 335 |
| End Cash Position | 2 | 2 | 1 | 2 | 28 |
| Net Cash Flow | $0 | $2 | $-2 | $-26 | $-307 |
| Free Cash Flow | |||||
| Operating Cash Flow | -789 | -1,697 | -2,275 | -1,448 | -2,415 |
| Capital Expenditure | -6 | 0 | -81 | -116 | -6 |
| Free Cash Flow | -795 | -1,697 | -2,355 | -1,564 | -2,421 |